Skip to main content

Maria Francesca Filippi Arriaga

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Maria Francesca Filippi Arriaga

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Sergio Hinojosa Sanz

Sergio Hinojosa Sanz

Cardiovascular Diseases
Read more
Gemma Parramon Puig

Gemma Parramon Puig

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Susana  Garcia  Bayona

Susana Garcia Bayona

Molecular Imaging and Therapy
Read more
Basilio Rodriguez  Diez

Basilio Rodriguez Diez

Senior researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.